NASDAQ:CRDF
Cardiff Oncology Inc. Stock News
$3.30
-0.160 (-4.62%)
At Close: May 23, 2024
Invitae : and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology | MarketScreener
11:01am, Monday, 22'nd Jun 2020Yasonna: Napi asimilasi dan integrasi yang berulah kembali 222 orang
07:32am, Monday, 22'nd Jun 2020
Menteri Hukum dan HAM Yasonna Laoly mengungkapkan hingga pertengahan Juni 2020, jumlah narapidana yang berulah kembali setelah dikeluarkan melalui program ...
Sorrento Therapeutics (NASDAQ:SRNE) vs. TrovaGene (NASDAQ:TROV) Head-To-Head Comparison
01:16am, Sunday, 21'st Jun 2020
Sorrento Therapeutics (NASDAQ:SRNE) and TrovaGene (NASDAQ:TROV) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of the
Dr Reddy's launches generic prostate cancer treatment drug in US
05:42pm, Friday, 19'th Jun 2020
Pharma major Dr Reddy's Laboratories on Friday said it has launched generic Abiraterone Acetate tablets, used for treatment of prostate cancer, in the US market.
Cardiff Oncology Raises $13.5M in Equity Funding | FinSMEs
09:47pm, Wednesday, 17'th Jun 2020
Cardiff Oncology, Inc. (Nasdaq: CRDF), a San Diego, CA-based clinical-stage oncology therapeutics company, has entered into a securities purchase agreement, which includes common stock, non-voting Ser
Pagaya Announces $102 Million Series D Funding Round | | IT Business Net
09:01am, Wednesday, 17'th Jun 2020
Forever-changing asset management, Pagaya sets a new standard with its technology Mega funding round amid global economic crisis signals heightened demand for Pagaya's data-driven investment stra
Pagaya Announces $102 Million Series D Funding Round
12:00am, Wednesday, 17'th Jun 2020
Pagaya, a global financial technology company using artificial intelligence (AI) to reshape asset management and institutional investment, today annou
Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage oncology therapeutics company developing drugs to treat cancers with the greatest medical need for new treatment options, including KRAS-mutated
Covid-19, Immunity and Fat Burning: What’s the Connection? | WholeFoods Magazine
02:42am, Tuesday, 16'th Jun 2020
If you’re reading this article, you’ve got to be wondering: What possible connection could there be between a “fat-burning metabolism” and COVID-19? Fat-burning sounds great when you’re ta
Subsidize your step into cover crops
08:06pm, Monday, 15'th Jun 2020
Help from the government and corporations is available to offset the cost of farmers’ investment in cover crops.
Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage oncology therapeutics company developing drugs to treat cancers with the greatest medical need for new treatment options, including KRAS-mutated
How conservation can pay for itself
08:11pm, Friday, 12'th Jun 2020
Data from Precision Conservation Management helps farmers like Adam Brown determine return on investment for conservation practices before making the switch.
ArcherDx Begins U.S. IPO Rollout (Pending:RCHR)
07:03pm, Thursday, 11'th Jun 2020
ArcherDx has filed to raise $100 million in an IPO, although the final figure may differ. The firm provides a variety of products for precision oncology researc
